Novel dedifferentiated liposarcoma xenograft models reveal PTEN down-regulation as a malignant signature and response to PI3K pathway inhibition.
第一作者:
Kathleen B,Smith
第一单位:
Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, California 90095, USA.
作者:
医学主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);动物(Animals);细胞分化(Cell Differentiation);细胞增殖(Cell Proliferation);减量调节(Down-Regulation);女(雌)性(Female);基因表达谱(Gene Expression Profiling);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);人类(Humans);脂类代谢(Lipid Metabolism);脂肪肉瘤(Liposarcoma);男(雄)性(Male);小鼠(Mice);中年人(Middle Aged);肿瘤侵润(Neoplasm Invasiveness);PTEN磷酸水解酶(PTEN Phosphohydrolase);磷酸肌醇3-激酶类(Phosphatidylinositol 3-Kinases);蛋白激酶抑制剂(Protein Kinase Inhibitors);信号传导(Signal Transduction);TOR丝氨酸-苏氨酸激酶(TOR Serine-Threonine Kinases);增量调节(Up-Regulation);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays)
DOI
10.1016/j.ajpath.2013.01.002
PMID
23416162
发布时间
2022-03-31
基金项目
P50 CA086306/CA/NCI NIH HHS/United States
T32 CA009056/CA/NCI NIH HHS/United States
- 浏览4
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



